| scholarly article | Q13442814 |
| P50 | author | John E Harris | Q90321378 |
| James P Strassner | Q88596432 | ||
| P2093 | author name string | Kingsley I Essien | |
| Jillian M Richmond | |||
| P2860 | cites work | An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation | Q89454382 |
| Peripheral Tissue Chemokines: Homeostatic Control of Immune Surveillance T Cells | Q90004463 | ||
| A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity | Q90965765 | ||
| Mouse Model for Human Vitiligo | Q91727091 | ||
| Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo | Q93037335 | ||
| CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells | Q22010907 | ||
| Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response | Q24613860 | ||
| Identification of human CCR8 as a CCL18 receptor | Q24618546 | ||
| Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling | Q24647357 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress | Q24650866 | ||
| Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells | Q24676386 | ||
| CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. | Q36677670 | ||
| TSLP in epithelial cell and dendritic cell cross talk | Q36819179 | ||
| From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch | Q36914941 | ||
| TSLP acts on infiltrating effector T cells to drive allergic skin inflammation | Q36954478 | ||
| Cutting Edge: Chemokine receptor CCR4 is necessary for antigen-driven cutaneous accumulation of CD4 T cells under physiological conditions. | Q36955664 | ||
| CCR6 as a possible therapeutic target in psoriasis | Q36980670 | ||
| Molecular signatures define alopecia areata subtypes and transcriptional biomarkers | Q37008476 | ||
| CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease | Q37065718 | ||
| Hormonal regulation of B-cell function and systemic lupus erythematosus | Q37186307 | ||
| Reduced skin homing by functional Treg in vitiligo | Q37187413 | ||
| CCR6 is required for IL-23-induced psoriasis-like inflammation in mice | Q37286597 | ||
| CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo | Q37299737 | ||
| Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice | Q37376897 | ||
| Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. | Q37468713 | ||
| Memory regulatory T cells reside in human skin | Q37602195 | ||
| Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice | Q37700821 | ||
| Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis | Q37709681 | ||
| Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates | Q37778645 | ||
| CXCR3 ligands: redundant, collaborative and antagonistic functions | Q37827339 | ||
| Harnessing dendritic cells in inflammatory skin diseases. | Q37835969 | ||
| Cockroach induces inflammatory responses through protease-dependent pathways | Q37885639 | ||
| The human cutaneous chemokine system. | Q38008335 | ||
| Regulation of cellular processes by interleukin-16 in homeostasis and cancer | Q38124813 | ||
| Chemokine receptors in psoriasis | Q38144211 | ||
| Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. | Q38178160 | ||
| Chemokines and chemokine receptors: positioning cells for host defense and immunity | Q38198156 | ||
| Mechanisms regulating skin immunity and inflammation | Q38203783 | ||
| The origins and functions of dendritic cells and macrophages in the skin | Q38214043 | ||
| The immunopathology of cutaneous lupus erythematosus | Q38230698 | ||
| CCR4 and its ligands: from bench to bedside | Q38236403 | ||
| Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis | Q38412949 | ||
| CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation | Q38456783 | ||
| TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis | Q38647664 | ||
| Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. | Q38683576 | ||
| Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor | Q24683742 | ||
| Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential | Q26744275 | ||
| CXCL14 as an emerging immune and inflammatory modulator | Q26770790 | ||
| Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis | Q26774652 | ||
| The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing | Q26830246 | ||
| Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation | Q27317270 | ||
| Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex | Q27679932 | ||
| Pseudoexons and regulatory elements in the genomic sequence of the beta-chemokine, alternative macrophage activation-associated CC-chemokine (AMAC)-1 | Q28144510 | ||
| Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils | Q28205971 | ||
| Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) | Q28211911 | ||
| CCL27-CCR10 interactions regulate T cell-mediated skin inflammation | Q28217086 | ||
| DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
| Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells | Q28302789 | ||
| CCR6 regulates the migration of inflammatory and regulatory T cells | Q28511778 | ||
| Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1 | Q28591681 | ||
| T-Cell Function and Migration — Two Sides of the Same Coin | Q29041098 | ||
| CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors | Q30432672 | ||
| Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice | Q30433217 | ||
| Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model | Q30498155 | ||
| Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. | Q30528857 | ||
| Sensing and alarm function of resident memory CD8⁺ T cells | Q30539038 | ||
| Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways | Q30543898 | ||
| Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine | Q30585157 | ||
| CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin | Q33390838 | ||
| Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring | Q33745172 | ||
| Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis | Q33760897 | ||
| Alopecia areata, stress and psychiatric disorders: a review | Q33770351 | ||
| CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo | Q33864128 | ||
| Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis | Q33941199 | ||
| Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. | Q33970584 | ||
| A mechanism for the initiation of allergen-induced T helper type 2 responses | Q34010133 | ||
| Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. | Q34024439 | ||
| The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities | Q34076431 | ||
| Sensing the outside world: TSLP regulates barrier immunity. | Q34076759 | ||
| Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis | Q47651802 | ||
| Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clones. | Q47748712 | ||
| Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice | Q47759791 | ||
| Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. | Q47929993 | ||
| IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells into Mucosal Tissues | Q47944236 | ||
| Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus | Q48361989 | ||
| Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis. | Q49985388 | ||
| Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3. | Q50014282 | ||
| CCR8 Expression Defines Tissue-Resident Memory T Cells in Human Skin. | Q50088147 | ||
| Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype. | Q50138116 | ||
| RNA Aptamers Recognizing Murine CCL17 Inhibit T Cell Chemotaxis and Reduce Contact Hypersensitivity In Vivo. | Q50149925 | ||
| Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. | Q50246489 | ||
| Preferential migration of T regulatory cells induced by IL-16. | Q50658836 | ||
| Differing requirements for CCR4, E-selectin, and α4β1 for the migration of memory CD4 and activated T cells to dermal inflammation. | Q50952121 | ||
| Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea. | Q51031439 | ||
| Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. | Q51066393 | ||
| Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo. | Q51075988 | ||
| CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice. | Q51167268 | ||
| Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. | Q51448115 | ||
| Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. | Q51637913 | ||
| Structure and Distribution of an Unrecognized Interstitium in Human Tissues. | Q51731097 | ||
| Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. | Q51983318 | ||
| The vast majority of CLA+ T cells are resident in normal skin. | Q51984006 | ||
| CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. | Q51995031 | ||
| FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. | Q51998740 | ||
| Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing. | Q52587547 | ||
| Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin. | Q52616118 | ||
| CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice. | Q52728536 | ||
| Correlation between serum IL-16 and atopic dermatitis. | Q53128421 | ||
| Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study. | Q53174921 | ||
| Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. | Q53246365 | ||
| Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis. | Q53257944 | ||
| Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. | Q53318728 | ||
| Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. | Q53461072 | ||
| Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib. | Q53662237 | ||
| Interferon-gamma-deficient mice are resistant to the development of alopecia areata. | Q53766814 | ||
| Topical Ruxolitinib for the Treatment of Alopecia Universalis. | Q54229292 | ||
| Crosstalk between TGF-β1 and CXCR3 signaling during urethral fibrosis. | Q54346484 | ||
| CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. | Q54434490 | ||
| Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. | Q54439509 | ||
| Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis. | Q54459614 | ||
| Association between IL16 gene polymorphisms and susceptibility to alopecia areata in the Korean population. | Q54469372 | ||
| JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis. | Q54513818 | ||
| Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. | Q54664588 | ||
| Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. | Q55519143 | ||
| Alopecia Areata | Q56286428 | ||
| CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression | Q56900772 | ||
| Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans | Q56901852 | ||
| CC Chemokine Ligand 18, An Atopic Dermatitis-Associated and Dendritic Cell-Derived Chemokine, Is Regulated by Staphylococcal Products and Allergen Exposure | Q56966131 | ||
| Substance P as an Immunomodulatory Neuropeptide in a Mouse Model for Autoimmune Hair Loss (Alopecia Areata) | Q56990592 | ||
| Type I interferon signature in the initiation of the immune response in vitiligo | Q56996562 | ||
| Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression | Q38718909 | ||
| Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment | Q38731631 | ||
| Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. | Q38732156 | ||
| Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? | Q38733185 | ||
| Understanding autoimmunity of vitiligo and alopecia areata | Q38837287 | ||
| Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus | Q38857518 | ||
| Drug-induced cutaneous lupus erythematosus: 88 new cases. | Q38995512 | ||
| Skin-derived TSLP systemically expands regulatory T cells | Q38996948 | ||
| JAK inhibitors in dermatology: The promise of a new drug class | Q39111032 | ||
| Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients. | Q39212867 | ||
| Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes | Q39253844 | ||
| Overexpression of CXCL16 in lesional psoriatic skin | Q39533961 | ||
| CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata | Q39604573 | ||
| A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation | Q39737420 | ||
| Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch | Q40058426 | ||
| Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo | Q40072169 | ||
| Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin | Q40158221 | ||
| Elevated homocysteine levels in suction-induced blister fluid of active vitiligo lesions | Q40200413 | ||
| Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis | Q40332185 | ||
| The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis | Q40414812 | ||
| Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. | Q40425124 | ||
| Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? | Q40506697 | ||
| Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2. | Q40533463 | ||
| Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function | Q40554316 | ||
| Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing | Q40598102 | ||
| CCR4 in human allergen-induced late responses in the skin and lung | Q40718567 | ||
| Baricitinib in Patients with Refractory Rheumatoid Arthritis | Q40735626 | ||
| Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4 | Q40794919 | ||
| A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. | Q40821601 | ||
| Cutting Edge: memory regulatory t cells require IL-7 and not IL-2 for their maintenance in peripheral tissues | Q40911505 | ||
| Renbok phenomenon and contact sensitization in a patient with alopecia universalis | Q41171805 | ||
| The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis | Q41620801 | ||
| T cell memory. Skin-resident memory CD8⁺ T cells trigger a state of tissue-wide pathogen alert. | Q41717756 | ||
| Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma | Q41789272 | ||
| Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies | Q41932624 | ||
| Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue | Q42048427 | ||
| A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin | Q42145851 | ||
| The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. | Q42259563 | ||
| In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease | Q42480631 | ||
| Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone | Q42492052 | ||
| Autocrine regulation of re-epithelialization after wounding by chemokine receptors CCR1, CCR10, CXCR1, CXCR2, and CXCR3. | Q42493138 | ||
| Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation | Q42509243 | ||
| Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells | Q42767760 | ||
| SFRP2/DPP4 and FMO1/LSP1 define major fibroblast populations in human skin | Q42778321 | ||
| Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis | Q43099559 | ||
| Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition | Q43630149 | ||
| Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus | Q43699034 | ||
| CXCR3 deficiency prolongs Th1-type contact hypersensitivity | Q43806136 | ||
| House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, Der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. | Q44172242 | ||
| Regulatory T Cells in Skin Facilitate Epithelial Stem Cell Differentiation. | Q44479151 | ||
| Demonstration of rebound phenomenon following abrupt withdrawal of the JAK1 inhibitor oclacitinib | Q44868185 | ||
| Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3. | Q34083641 | ||
| Anti-angiogenic effects of epigallocatechin-3-gallate in human skin | Q34104237 | ||
| CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. | Q34156849 | ||
| Inflammatory dendritic cells--not basophils--are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen | Q34161524 | ||
| Homing and cellular traffic in lymph nodes | Q34282818 | ||
| Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo | Q34287499 | ||
| The role of substance P in inflammatory disease | Q34343982 | ||
| An early reduction in Treg cells correlates with enhanced local inflammation in cutaneous leishmaniasis in CCR6-deficient mice | Q34427121 | ||
| Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. | Q34433867 | ||
| Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells | Q34444540 | ||
| Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy | Q34482156 | ||
| Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site | Q34510273 | ||
| Chemokines and the tissue-specific migration of lymphocytes | Q34515703 | ||
| Proton pump inhibitor-induced subacute cutaneous lupus erythematosus | Q34516486 | ||
| Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers. | Q34523843 | ||
| Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata | Q34541893 | ||
| Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. | Q34541899 | ||
| Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis | Q34616359 | ||
| T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells | Q34626234 | ||
| The IL-21 receptor augments Th2 effector function and alternative macrophage activation | Q34682153 | ||
| Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines | Q34762409 | ||
| Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. | Q34966662 | ||
| CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. | Q35006074 | ||
| Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities | Q35084580 | ||
| The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. | Q35132544 | ||
| Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses | Q35184456 | ||
| Alopecia areata: treatment of today and tomorrow | Q35190527 | ||
| Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. | Q35586076 | ||
| Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis | Q35620315 | ||
| Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. | Q35773559 | ||
| Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib | Q35800753 | ||
| Small Molecule CXCR3 Antagonists | Q35831696 | ||
| Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease | Q35848458 | ||
| CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System | Q57209761 | ||
| Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene | Q57338189 | ||
| Punch Grafting versus Suction Blister Epidermal Grafting in the Treatment of Stable Lip Vitiligo | Q58623428 | ||
| Cutting Edge: Expression of Chemokine Receptor CXCR1 on Human Effector CD8+ T Cells | Q58755839 | ||
| Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo | Q59356549 | ||
| Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor | Q60843768 | ||
| Melanocytes in psoriasis: convicted culprit or bullied bystander? | Q64973006 | ||
| Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta | Q68556740 | ||
| Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study | Q71038378 | ||
| Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis | Q71829930 | ||
| Alopecia areata in aging C3H/HeJ mice | Q72001887 | ||
| Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients | Q72037404 | ||
| Lesional expression of interferon-gamma in atopic eczema | Q72665549 | ||
| The effect of hormonal changes on cutaneous disease in lupus erythematosus | Q72919038 | ||
| Role of cytotoxic T cells in chronic alopecia areata | Q73322016 | ||
| "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation | Q73565836 | ||
| Increased basic fibroblast growth factor levels in serum and blister fluid from patients with vitiligo | Q73598017 | ||
| The human hair follicle immune system: cellular composition and immune privilege | Q73789525 | ||
| Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease | Q74027234 | ||
| Modified technique of suction blistering for epidermal grafting in vitiligo | Q77734510 | ||
| Gene expression in bronchoalveolar lavage cells from scleroderma patients | Q77995648 | ||
| Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo | Q78195032 | ||
| Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference | Q79872393 | ||
| CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli | Q79951348 | ||
| Fucosyltransferase VII-positive, skin-homing T cells in the blood and skin lesions of atopic dermatitis patients | Q80172728 | ||
| Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack | Q80413604 | ||
| The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets | Q80832474 | ||
| Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model | Q81009296 | ||
| Interleukin-16 in patients with alopecia areata | Q81198812 | ||
| Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege | Q81283837 | ||
| Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus | Q81349191 | ||
| CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells | Q82661651 | ||
| CCL18 is expressed in patients with bullous pemphigoid and parallels disease course | Q83140582 | ||
| Investigation of the inflammatory mechanisms in alopecia areata | Q83207634 | ||
| Type 1 interferon signature in the scalp lesions of alopecia areata | Q83932317 | ||
| Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis | Q84236518 | ||
| CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase | Q85891593 | ||
| Atopic dermatitis | Q86174273 | ||
| Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata | Q86489325 | ||
| Promoter demethylation contributes to TSLP overexpression in skin lesions of patients with atopic dermatitis | Q86954617 | ||
| Understanding how cutaneous lupus erythematosus progresses to systemic lupus erythematosus | Q87194335 | ||
| Dupilumab treatment in adults with moderate-to-severe atopic dermatitis | Q87371931 | ||
| Stratum corneum profiles of inflammatory mediators in patch test reactions to common contact allergens and sodium lauryl sulfate | Q87768981 | ||
| Piezo2 channel-Merkel cell signaling modulates the conversion of touch to itch | Q88562137 | ||
| JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositis | Q89004946 | ||
| Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation | Q89060748 | ||
| Regulatory T cells in autoimmune disease | Q89171054 | ||
| TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice | Q44998295 | ||
| Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. | Q45054355 | ||
| Dermal clusters of mature dendritic cells and T cells are associated with the CCL20/CCR6 chemokine system in chronic psoriasis | Q45847335 | ||
| Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade | Q45897140 | ||
| Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. | Q45950978 | ||
| Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity | Q46312769 | ||
| The role of interleukin-16 in murine contact hypersensitivity | Q46419639 | ||
| Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel | Q46685847 | ||
| CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. | Q46760246 | ||
| CCR4 and CCR10 ligands play additive roles in mouse contact hypersensitivity | Q46839201 | ||
| The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak | Q46861210 | ||
| Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity | Q46871487 | ||
| Sensory TRP channels contribute differentially to skin inflammation and persistent itch. | Q47132169 | ||
| Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. | Q47324915 | ||
| Role of chemokines and the corresponding receptors in vitiligo: A pilot study | Q47426230 | ||
| Cytokine modulation of atopic itch | Q89211309 | ||
| Melanocyte antigen triggers autoimmunity in human psoriasis | Q35856465 | ||
| Lymphocytes, neuropeptides, and genes involved in alopecia areata | Q35916135 | ||
| Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse. | Q35962329 | ||
| Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages | Q36021832 | ||
| JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases | Q36155239 | ||
| Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity | Q36165375 | ||
| Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease. | Q36176403 | ||
| Targeting chemokine receptor CCR4 in adult T-cell leukemia-lymphoma and other T-cell lymphomas | Q36183430 | ||
| Probing the effects of stress mediators on the human hair follicle: substance P holds central position | Q36202856 | ||
| Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease | Q36229433 | ||
| Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. | Q36241951 | ||
| IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells | Q36304913 | ||
| Neuroimmunoendocrine circuitry of the 'brain-skin connection'. | Q36306022 | ||
| Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles | Q36307704 | ||
| Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin | Q36323325 | ||
| CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin | Q36370073 | ||
| How are T(H)2-type immune responses initiated and amplified? | Q36394985 | ||
| A skin-selective homing mechanism for human immune surveillance T cells | Q36399490 | ||
| Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin | Q36402793 | ||
| A vaccine strategy that protects against genital herpes by establishing local memory T cells | Q36403540 | ||
| Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). | Q36479531 | ||
| The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design | Q36547207 | ||
| Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases | Q36553595 | ||
| P433 | issue | 1 | |
| P921 | main subject | skin disease | Q949302 |
| P304 | page(s) | 186-204 | |
| P577 | publication date | 2019-05-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | T-cell positioning by chemokines in autoimmune skin diseases | |
| P478 | volume | 289 |
| Q97588865 | Development and characterization of novel mouse monoclonal antibodies against chicken chemokine CC motif ligand 4 | cites work | P2860 |
Search more.